Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
At close: Dec 4, 2025
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 51.22 million as of December 5, 2025. Its market cap has decreased by -24.07% in one year.
Market Cap
51.22M
Enterprise Value
29.77M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 51.22M, an increase of 219.35%. That is a compound annual growth rate of 6.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 105.71B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 1.33B |
| BrainsWay | 1.08B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 997.78M |
| Ilex Medical | 717.72M |
| Novolog (Pharm-Up 1966) | 644.72M |